Last Updated : September 28, 2023
Canada's Drug Agency Program Updates
Details
Review Type: Rapid
Provisional Funding Algorithm |
|
|---|---|
| Draft Report Posted | September 28, 2023 |
| Stakeholder Feedback Deadline | October 5, 2023 |
| Final Report Posted | October 27, 2023 |
Last Updated : October 27, 2023
Details
| Call for patient/clinician input open | 24-May-23 |
|---|---|
| Call for patient/clinician input closed | 14-Jul-23 |
| Clarification: - Patient input submission received from Canadian Heart Patient Alliance and HeartLife Foundation | |
| Submission received | 19-Sep-23 |
| Submission accepted | 04-Oct-23 |
| Review initiated | 05-Oct-23 |
| Draft CADTH review report(s) provided to sponsor for comment | 20-Dec-23 |
| Deadline for sponsors comments | 08-Jan-24 |
| CADTH review report(s) and responses to comments provided to sponsor | 15-Feb-24 |
| Expert committee meeting (initial) | 28-Feb-24 |
| Draft recommendation issued to sponsor | 13-Mar-24 |
| Draft recommendation posted for stakeholder feedback | 21-Mar-24 |
| End of feedback period | 08-Apr-24 |
| Final recommendation issued to sponsor and drug plans | 22-Apr-24 |
| Final recommendation posted | 09-May-24 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 29-Aug-24 |
| CADTH review report(s) posted | 20-Dec-24 |
Last Updated : December 20, 2024
Details
| Call for patient/clinician input open | 25-Sep-23 |
|---|---|
| Call for patient/clinician input closed | 21-Nov-23 |
| Clarification: - Patient input submission received from Melanoma Canada, and Save Your Skin Foundation | |
| Submission received | 06-Nov-23 |
| Submission accepted | 21-Nov-23 |
| Review initiated | 22-Nov-23 |
| Draft Canada's Drug Agency review report(s) provided to sponsor for comment | 15-Feb-24 |
| Deadline for sponsors comments | 27-Feb-24 |
| Canada's Drug Agency review report(s) and responses to comments provided to sponsor | 28-Mar-24 |
| Expert committee meeting (initial) | 10-Apr-24 |
| Draft recommendation issued to sponsor | 22-Apr-24 |
| Draft recommendation posted for stakeholder feedback | 02-May-24 |
| End of feedback period | 16-May-24 |
| Final recommendation issued to sponsor and drug plans | 29-May-24 |
| Final recommendation posted | 14-Jun-24 |
| Deadline for sponsor to submit redaction requests on draft Canada's Drug Agency review report(s) | 12-Jun-24 |
| Canada's Drug Agency review report(s) posted | 26-Sep-24 |
Last Updated : September 26, 2024
Details
| Call for patient/clinician input open | September 20, 2023 |
|---|---|
| Call for patient/clinician input closed | November 14, 2023 |
| Clarification: - Patient input submission received from the Canadian Skin Patient Alliance, Eczema Society of Canada and Eczéma Québec | |
| Submission received | November 01, 2023 |
| Submission accepted | November 16, 2023 |
| Review initiated | November 17, 2023 |
| Draft CADTH review report(s) provided to sponsor for comment | February 08, 2024 |
| Deadline for sponsors comments | February 20, 2024 |
| CADTH review report(s) and responses to comments provided to sponsor | March 14, 2024 |
| Expert committee meeting (initial) | March 27, 2024 |
| Draft recommendation issued to sponsor | July 08, 2024 |
| Clarification: - CDEC recommendation held pending receipt of NOC and evaluation of the finalized submission requirements. | |
| Draft recommendation posted for stakeholder feedback | July 18, 2024 |
| End of feedback period | August 01, 2024 |
| Clarification: - Reconsideration: major revisions requested by sponsor | |
| Expert committee meeting | September 25, 2024 |
| Final recommendation issued to sponsor and drug plans | October 09, 2024 |
| Final recommendation posted | November 15, 2024 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | October 24, 2024 |
| CADTH review report(s) posted | February 11, 2025 |
Last Updated : February 11, 2025
Details
| Call for patient/clinician input open | 15-Sep-23 |
|---|---|
| Call for patient/clinician input closed | 14-Nov-23 |
| Clarification: - No patient input submission received | |
| Submission received | 30-Oct-23 |
| Submission accepted | 14-Nov-23 |
| Review initiated | 15-Nov-23 |
| Draft CADTH review report(s) provided to sponsor for comment | 08-Feb-24 |
| Clarification: - Voluntarily withdrawn by the sponsor on 14-May-2024 | |
| Deadline for sponsors comments | 20-Feb-24 |
| Clarification: - Submission temporarily suspended - Temporary suspension of the review has been lifted | |
Last Updated : April 30, 2025
Details
| Call for patient/clinician input open | 14-Sep-23 |
|---|---|
| Call for patient/clinician input closed | 21-Nov-23 |
| Submission received | 27-Oct-23 |
| Submission accepted | 17-Nov-23 |
| Clarification: - Submission was not accepted for review on 10 Nov 2023 | |
| Review initiated | 20-Nov-23 |
| Clarification: - Submission temporarily suspended - Additional information has been received and the temporary suspension of the review has been lifted on 28 Aug 2024 | |
| Draft CADTH review report(s) provided to sponsor for comment | 16-Oct-24 |
| Deadline for sponsors comments | 25-Oct-24 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 15-Nov-24 |
| Expert committee meeting (initial) | 27-Nov-24 |
| Draft recommendation issued to sponsor | 11-Dec-24 |
| Draft recommendation posted for stakeholder feedback | 19-Dec-24 |
| End of feedback period | 10-Jan-25 |
| Clarification: - Reconsideration: major revisions requested by sponsor - Target CDEC reconsideration meeting date to be determined | |
| Expert committee meeting | 23-Apr-25 |
| Final recommendation issued to sponsor and drug plans | 06-May-25 |
| Final recommendation posted | - |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 21-May-25 |
| CDA-AMC review report(s) posted | - |
Last Updated : April 9, 2025
Details
Review Type: Rapid
Provisional Funding Algorithm |
|
|---|---|
| Draft Report Posted: | September 14, 2023 |
| Stakeholder Feedback Deadline: | September 21, 2023 |
| Final Report Posted: | October 27, 2023 |
Last Updated : October 27, 2023
Details
| Call for patient/clinician input open | September 05, 2023 |
|---|---|
| Call for patient/clinician input closed | October 30, 2023 |
| Clarification: - No patient input submission received | |
| Submission received | October 18, 2023 |
| Submission accepted | November 01, 2023 |
| Review initiated | November 02, 2023 |
| Draft CADTH review report(s) provided to sponsor for comment | January 29, 2024 |
| Deadline for sponsors comments | February 07, 2024 |
| CADTH review report(s) and responses to comments provided to sponsor | March 01, 2024 |
| Expert committee meeting (initial) | March 13, 2024 |
| Draft recommendation issued to sponsor | March 27, 2024 |
| Draft recommendation posted for stakeholder feedback | April 04, 2024 |
| End of feedback period | April 18, 2024 |
| Final recommendation issued to sponsor and drug plans | May 03, 2024 |
| Final recommendation posted | May 22, 2024 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | May 17, 2024 |
| CADTH review report(s) posted | July 24, 2024 |
Last Updated : January 29, 2025
Details
| Call for patient/clinician input open | 06-Sep-23 |
|---|---|
| Call for patient/clinician input closed | 30-Oct-23 |
| Clarification: - Patient input submission received from Diabetes Canada | |
| Submission received | 18-Oct-23 |
| Submission accepted | 01-Nov-23 |
| Review initiated | 02-Nov-23 |
| Draft Canada's Drug Agency review report(s) provided to sponsor for comment | 01-Feb-24 |
| Deadline for sponsors comments | 12-Feb-24 |
| Canada's Drug Agency review report(s) and responses to comments provided to sponsor | 14-Mar-24 |
| Expert committee meeting (initial) | 27-Mar-24 |
| Draft recommendation issued to sponsor | 11-Apr-24 |
| Draft recommendation posted for stakeholder feedback | 18-Apr-24 |
| End of feedback period | 03-May-24 |
| Final recommendation issued to sponsor and drug plans | 17-May-24 |
| Final recommendation posted | 05-Jun-24 |
| Deadline for sponsor to submit redaction requests on draft Canada's Drug Agency review report(s) | 03-Jun-24 |
| Canada's Drug Agency review report(s) posted | 27-Sep-24 |
Last Updated : October 3, 2024